ZA987662B - Neospora Vaccine. - Google Patents

Neospora Vaccine.

Info

Publication number
ZA987662B
ZA987662B ZA9807662A ZA987662A ZA987662B ZA 987662 B ZA987662 B ZA 987662B ZA 9807662 A ZA9807662 A ZA 9807662A ZA 987662 A ZA987662 A ZA 987662A ZA 987662 B ZA987662 B ZA 987662B
Authority
ZA
South Africa
Prior art keywords
neospora vaccine
neospora
vaccine
Prior art date
Application number
ZA9807662A
Other languages
English (en)
Inventor
David Alan Brake
Manuel Campos
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22007613&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA987662(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ZA987662B publication Critical patent/ZA987662B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA9807662A 1997-08-26 1998-08-25 Neospora Vaccine. ZA987662B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5695697P 1997-08-26 1997-08-26

Publications (1)

Publication Number Publication Date
ZA987662B true ZA987662B (en) 2000-02-25

Family

ID=22007613

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9807662A ZA987662B (en) 1997-08-26 1998-08-25 Neospora Vaccine.

Country Status (16)

Country Link
US (2) US6787146B2 (xx)
EP (2) EP0898969B1 (xx)
JP (1) JP3049016B2 (xx)
CN (1) CN1211449A (xx)
AR (1) AR016396A1 (xx)
AT (1) ATE277631T1 (xx)
AU (1) AU764455B2 (xx)
BR (1) BR9803232A (xx)
CA (1) CA2245425C (xx)
DE (1) DE69826593T2 (xx)
DK (1) DK0898969T3 (xx)
ES (1) ES2227783T3 (xx)
NZ (1) NZ331529A (xx)
PT (1) PT898969E (xx)
TW (2) TWI228419B (xx)
ZA (1) ZA987662B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69836976T2 (de) * 1997-10-20 2007-11-08 Bayer Corp. Neospora impstoff
EP0953641A3 (en) * 1998-03-26 2002-03-13 Pfizer Products Inc. Polynucleotide molecules encoding neospora proteins
ATE533506T1 (de) * 2002-08-26 2011-12-15 Pfizer Prod Inc Impfstoff gegen das fortpflanzungs- und atmungssyndrom bei rindern
JP2006512942A (ja) * 2002-10-25 2006-04-20 ユニバーシティー オブ コネティカット ヘルス センター 制御細胞溶解による癌の免疫療法のための装置と方法
WO2005118884A1 (en) * 2004-05-28 2005-12-15 The United States Of America As Represented By The Secretary Of The Navy A method for the rapid diagnosis of infectious disease by detection and quantitation of microorganism induced cytokines
ES2319242B1 (es) 2005-12-23 2009-12-01 Laboratorios Hipra, S.A. Aislado avirulento de neospora canimum y sus usos.
ES2326770B1 (es) 2007-07-13 2010-07-26 Universidad Complutense De Madrid Uso de un nuevo aislado de neospora caninum para el desarrollo de pruebas de diagnostico y para la fabricacion de productos para el tratamiento y prevencion de la infenccion causada por neospora.
CN101831495B (zh) * 2010-04-30 2013-06-19 新疆出入境检验检疫局检验检疫技术中心 一种牛新孢子虫病的检测方法及应用
EP2708237A1 (en) * 2012-09-17 2014-03-19 Université de Droit et de la Santé de Lille 2 Pharmaceutical composition for its use in the preventive treatment of infections caused by an intracellular pathogen, more particularly Toxoplasma gondii
US9649370B2 (en) 2013-05-08 2017-05-16 Protatek International, Inc. Vaccine for PCV2 and mycoplasma
MX2018005254A (es) * 2015-10-28 2019-10-04 Univ Madrid Complutense Composicion de una vacuna de neospora.
UA125029C2 (uk) 2016-10-05 2021-12-29 Зоетіс Сервісіс Ллк Спосіб ліофілізації, який забезпечує стабільно дегідратовані найпростіші для застосування як ефективних живих вакцин

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643718A (en) * 1993-11-04 1997-07-01 The Board Of Trustees Of The Leland Stanford Junior University Transfection and genetic manipulations in obligate intracellular parasites
US5707617A (en) * 1994-03-21 1998-01-13 The Regents Of The University Of California Bovine neospora isolates
US5889166A (en) * 1996-05-10 1999-03-30 The Regents Of The University Of California Recombinant neospora antigens and their uses
US6743430B1 (en) 1995-03-29 2004-06-01 Richard E. Parizek Multicomponent vaccine containing clostridial and non-clostridial organisms in a low dose
CA2184132C (en) 1995-09-21 2011-03-15 Kristina J. Hennessy An adjuvanted vaccine which is substantially free of non-host albumin
WO1997017082A1 (en) 1995-11-09 1997-05-15 Trustees Of Dartmouth College A vaccine against toxoplasma gondii
EP0841392B1 (en) * 1996-11-12 2004-07-14 Pfizer Inc. Attenuated live neospora vaccine

Also Published As

Publication number Publication date
ATE277631T1 (de) 2004-10-15
US20020058046A1 (en) 2002-05-16
PT898969E (pt) 2005-01-31
ES2227783T3 (es) 2005-04-01
JP3049016B2 (ja) 2000-06-05
AU8188498A (en) 1999-03-11
EP0898969A2 (en) 1999-03-03
DK0898969T3 (da) 2005-01-17
TW200305433A (en) 2003-11-01
CA2245425C (en) 2006-12-12
AR016396A1 (es) 2001-07-04
EP0898969A3 (en) 2001-02-07
US20040223982A1 (en) 2004-11-11
DE69826593D1 (de) 2004-11-04
CA2245425A1 (en) 1999-02-26
DE69826593T2 (de) 2005-02-10
EP1477184A3 (en) 2006-04-12
JPH11130683A (ja) 1999-05-18
NZ331529A (en) 1999-03-29
AU764455B2 (en) 2003-08-21
EP1477184A2 (en) 2004-11-17
EP0898969B1 (en) 2004-09-29
TWI228419B (en) 2005-03-01
BR9803232A (pt) 2000-01-11
CN1211449A (zh) 1999-03-24
US6787146B2 (en) 2004-09-07

Similar Documents

Publication Publication Date Title
ZA9811849B (en) Vaccine.
ZA984969B (en) Vaccine.
ZA988789B (en) Vaccine.
GB9712347D0 (en) Vaccine
GB9718901D0 (en) Vaccine
GB9726555D0 (en) Vaccine
CY2410B1 (en) Novel device.
HK1016976A1 (en) Resorcinyl-triazine.
ZA981926B (en) Detergent--package combination.
ZA987055B (en) Substituted 4-benzoylpyrazoles.
DE59804842D1 (en) Aliphatische, emissionsarme, sinterfähige thermoplastische polyurethanformmassen
ZA978799B (en) Mycosis vaccine.
ZA987662B (en) Neospora Vaccine.
HK1017834A1 (en) Bodyshaper.
ZA983705B (en) Pregnan-3-ol-20-ones.
HK1016333A1 (en) Kara-ok device.
ZA987B (en) Substituted 4-benzoylpyrazoles.
ZA982763B (en) Vaccines
ZA981309B (en) 4-aminoalkoxy-1H-benzoimidazoles.
ZA983795B (en) Substituted 4-benzoyl-pyrazoles.
HK1014847A1 (en) Body-hair processor.
ZA983532B (en) Sensors.
ZA983698B (en) Estrenes.
ZA98263B (en) O-fucosyltransferase.
ZA987303B (en) Vaccine.